nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Dactinomycin—sarcoma	0.143	0.159	CbGbCtD
Fluorescein—ABCC1—Mitoxantrone—sarcoma	0.128	0.142	CbGbCtD
Fluorescein—ABCB11—Vincristine—sarcoma	0.124	0.138	CbGbCtD
Fluorescein—ABCC1—Epirubicin—sarcoma	0.104	0.115	CbGbCtD
Fluorescein—CYP1A1—Dacarbazine—sarcoma	0.102	0.113	CbGbCtD
Fluorescein—ABCC1—Vincristine—sarcoma	0.0881	0.0977	CbGbCtD
Fluorescein—ABCC1—Etoposide—sarcoma	0.0807	0.0895	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—sarcoma	0.0775	0.0859	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—sarcoma	0.0551	0.0611	CbGbCtD
Fluorescein—Chills—Thiotepa—sarcoma	0.000505	0.00514	CcSEcCtD
Fluorescein—Chills—Dactinomycin—sarcoma	0.000501	0.0051	CcSEcCtD
Fluorescein—Skin discolouration—Epirubicin—sarcoma	0.0005	0.00509	CcSEcCtD
Fluorescein—Bronchospasm—Etoposide—sarcoma	0.000497	0.00506	CcSEcCtD
Fluorescein—Hypoaesthesia—Vincristine—sarcoma	0.000497	0.00506	CcSEcCtD
Fluorescein—Bradycardia—Mitoxantrone—sarcoma	0.000495	0.00504	CcSEcCtD
Fluorescein—Erythema—Thiotepa—sarcoma	0.00049	0.00499	CcSEcCtD
Fluorescein—Erythema—Dactinomycin—sarcoma	0.000486	0.00495	CcSEcCtD
Fluorescein—Extravasation—Doxorubicin—sarcoma	0.000479	0.00487	CcSEcCtD
Fluorescein—Vasodilation—Doxorubicin—sarcoma	0.000475	0.00484	CcSEcCtD
Fluorescein—Vasodilation procedure—Doxorubicin—sarcoma	0.000475	0.00484	CcSEcCtD
Fluorescein—Cardiac disorder—Vincristine—sarcoma	0.000463	0.00472	CcSEcCtD
Fluorescein—Skin discolouration—Doxorubicin—sarcoma	0.000462	0.00471	CcSEcCtD
Fluorescein—Angiopathy—Vincristine—sarcoma	0.000453	0.00461	CcSEcCtD
Fluorescein—Ill-defined disorder—Dactinomycin—sarcoma	0.000451	0.00459	CcSEcCtD
Fluorescein—Mediastinal disorder—Vincristine—sarcoma	0.00045	0.00458	CcSEcCtD
Fluorescein—Malaise—Dactinomycin—sarcoma	0.000439	0.00447	CcSEcCtD
Fluorescein—Chills—Mitoxantrone—sarcoma	0.000436	0.00444	CcSEcCtD
Fluorescein—Cough—Thiotepa—sarcoma	0.000428	0.00435	CcSEcCtD
Fluorescein—Convulsion—Thiotepa—sarcoma	0.000425	0.00432	CcSEcCtD
Fluorescein—Erythema—Mitoxantrone—sarcoma	0.000423	0.00431	CcSEcCtD
Fluorescein—Hypertension—Thiotepa—sarcoma	0.000423	0.00431	CcSEcCtD
Fluorescein—Dysgeusia—Mitoxantrone—sarcoma	0.000414	0.00422	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000414	0.00422	CcSEcCtD
Fluorescein—Discomfort—Dactinomycin—sarcoma	0.000409	0.00417	CcSEcCtD
Fluorescein—Neoplasm—Epirubicin—sarcoma	0.000408	0.00415	CcSEcCtD
Fluorescein—Hypoaesthesia—Etoposide—sarcoma	0.000402	0.0041	CcSEcCtD
Fluorescein—Pulmonary oedema—Epirubicin—sarcoma	0.000402	0.00409	CcSEcCtD
Fluorescein—Oedema—Dactinomycin—sarcoma	0.000397	0.00404	CcSEcCtD
Fluorescein—Ill-defined disorder—Mitoxantrone—sarcoma	0.000393	0.004	CcSEcCtD
Fluorescein—Nervous system disorder—Thiotepa—sarcoma	0.000392	0.00399	CcSEcCtD
Fluorescein—Tachycardia—Thiotepa—sarcoma	0.00039	0.00397	CcSEcCtD
Fluorescein—Skin disorder—Thiotepa—sarcoma	0.000389	0.00396	CcSEcCtD
Fluorescein—Malaise—Mitoxantrone—sarcoma	0.000382	0.00389	CcSEcCtD
Fluorescein—Thrombophlebitis—Epirubicin—sarcoma	0.000379	0.00385	CcSEcCtD
Fluorescein—Neoplasm—Doxorubicin—sarcoma	0.000378	0.00384	CcSEcCtD
Fluorescein—Convulsion—Vincristine—sarcoma	0.000377	0.00383	CcSEcCtD
Fluorescein—Cardiac disorder—Etoposide—sarcoma	0.000375	0.00382	CcSEcCtD
Fluorescein—Hypertension—Vincristine—sarcoma	0.000375	0.00382	CcSEcCtD
Fluorescein—Pulmonary oedema—Doxorubicin—sarcoma	0.000372	0.00378	CcSEcCtD
Fluorescein—Cough—Mitoxantrone—sarcoma	0.000369	0.00376	CcSEcCtD
Fluorescein—Angiopathy—Etoposide—sarcoma	0.000367	0.00374	CcSEcCtD
Fluorescein—Convulsion—Mitoxantrone—sarcoma	0.000367	0.00373	CcSEcCtD
Fluorescein—Hypertension—Mitoxantrone—sarcoma	0.000365	0.00372	CcSEcCtD
Fluorescein—Immune system disorder—Etoposide—sarcoma	0.000365	0.00372	CcSEcCtD
Fluorescein—Eczema—Epirubicin—sarcoma	0.000365	0.00371	CcSEcCtD
Fluorescein—Mediastinal disorder—Etoposide—sarcoma	0.000364	0.00371	CcSEcCtD
Fluorescein—Chills—Etoposide—sarcoma	0.000363	0.00369	CcSEcCtD
Fluorescein—Chest pain—Mitoxantrone—sarcoma	0.00036	0.00367	CcSEcCtD
Fluorescein—Paraesthesia—Thiotepa—sarcoma	0.000359	0.00366	CcSEcCtD
Fluorescein—Discomfort—Mitoxantrone—sarcoma	0.000356	0.00362	CcSEcCtD
Fluorescein—Anaphylactic shock—Vincristine—sarcoma	0.000355	0.00361	CcSEcCtD
Fluorescein—Oedema—Vincristine—sarcoma	0.000355	0.00361	CcSEcCtD
Fluorescein—Hot flush—Epirubicin—sarcoma	0.00035	0.00357	CcSEcCtD
Fluorescein—Thrombophlebitis—Doxorubicin—sarcoma	0.00035	0.00357	CcSEcCtD
Fluorescein—Nervous system disorder—Vincristine—sarcoma	0.000348	0.00354	CcSEcCtD
Fluorescein—Menopausal symptoms—Epirubicin—sarcoma	0.000347	0.00354	CcSEcCtD
Fluorescein—Anaphylactic shock—Mitoxantrone—sarcoma	0.000345	0.00352	CcSEcCtD
Fluorescein—Oedema—Mitoxantrone—sarcoma	0.000345	0.00352	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Thiotepa—sarcoma	0.000345	0.00352	CcSEcCtD
Fluorescein—Dysgeusia—Etoposide—sarcoma	0.000345	0.00351	CcSEcCtD
Fluorescein—Hyperhidrosis—Vincristine—sarcoma	0.000343	0.00349	CcSEcCtD
Fluorescein—Pain—Thiotepa—sarcoma	0.000342	0.00348	CcSEcCtD
Fluorescein—Shock—Mitoxantrone—sarcoma	0.00034	0.00346	CcSEcCtD
Fluorescein—Pain—Dactinomycin—sarcoma	0.000339	0.00346	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Epirubicin—sarcoma	0.000339	0.00345	CcSEcCtD
Fluorescein—Eczema—Doxorubicin—sarcoma	0.000337	0.00343	CcSEcCtD
Fluorescein—Tachycardia—Mitoxantrone—sarcoma	0.000337	0.00343	CcSEcCtD
Fluorescein—Skin disorder—Mitoxantrone—sarcoma	0.000336	0.00342	CcSEcCtD
Fluorescein—Cerebrovascular accident—Epirubicin—sarcoma	0.000334	0.0034	CcSEcCtD
Fluorescein—Hyperhidrosis—Mitoxantrone—sarcoma	0.000334	0.0034	CcSEcCtD
Fluorescein—Hypotension—Vincristine—sarcoma	0.000331	0.00337	CcSEcCtD
Fluorescein—Feeling abnormal—Thiotepa—sarcoma	0.00033	0.00336	CcSEcCtD
Fluorescein—Feeling abnormal—Dactinomycin—sarcoma	0.000327	0.00333	CcSEcCtD
Fluorescein—Gastrointestinal pain—Thiotepa—sarcoma	0.000327	0.00333	CcSEcCtD
Fluorescein—Ill-defined disorder—Etoposide—sarcoma	0.000327	0.00333	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dactinomycin—sarcoma	0.000325	0.0033	CcSEcCtD
Fluorescein—Hot flush—Doxorubicin—sarcoma	0.000324	0.0033	CcSEcCtD
Fluorescein—Hypotension—Mitoxantrone—sarcoma	0.000323	0.00329	CcSEcCtD
Fluorescein—Menopausal symptoms—Doxorubicin—sarcoma	0.000321	0.00327	CcSEcCtD
Fluorescein—Paraesthesia—Vincristine—sarcoma	0.000318	0.00324	CcSEcCtD
Fluorescein—Urticaria—Thiotepa—sarcoma	0.000318	0.00323	CcSEcCtD
Fluorescein—Malaise—Etoposide—sarcoma	0.000317	0.00323	CcSEcCtD
Fluorescein—Abdominal pain—Thiotepa—sarcoma	0.000316	0.00322	CcSEcCtD
Fluorescein—Abdominal pain—Dactinomycin—sarcoma	0.000314	0.00319	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000313	0.00319	CcSEcCtD
Fluorescein—Cardiac arrest—Epirubicin—sarcoma	0.000312	0.00317	CcSEcCtD
Fluorescein—Paraesthesia—Mitoxantrone—sarcoma	0.00031	0.00316	CcSEcCtD
Fluorescein—Loss of consciousness—Etoposide—sarcoma	0.000309	0.00315	CcSEcCtD
Fluorescein—Cerebrovascular accident—Doxorubicin—sarcoma	0.000309	0.00315	CcSEcCtD
Fluorescein—Dyspnoea—Mitoxantrone—sarcoma	0.000308	0.00313	CcSEcCtD
Fluorescein—Cough—Etoposide—sarcoma	0.000307	0.00313	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vincristine—sarcoma	0.000306	0.00312	CcSEcCtD
Fluorescein—Convulsion—Etoposide—sarcoma	0.000305	0.00311	CcSEcCtD
Fluorescein—Hypertension—Etoposide—sarcoma	0.000304	0.00309	CcSEcCtD
Fluorescein—Pain—Vincristine—sarcoma	0.000303	0.00309	CcSEcCtD
Fluorescein—Chest pain—Etoposide—sarcoma	0.0003	0.00305	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000298	0.00303	CcSEcCtD
Fluorescein—Discomfort—Etoposide—sarcoma	0.000296	0.00301	CcSEcCtD
Fluorescein—Pain—Mitoxantrone—sarcoma	0.000295	0.00301	CcSEcCtD
Fluorescein—Hypersensitivity—Thiotepa—sarcoma	0.000295	0.003	CcSEcCtD
Fluorescein—Hypersensitivity—Dactinomycin—sarcoma	0.000292	0.00298	CcSEcCtD
Fluorescein—Gastrointestinal pain—Vincristine—sarcoma	0.00029	0.00295	CcSEcCtD
Fluorescein—Cardiac arrest—Doxorubicin—sarcoma	0.000288	0.00293	CcSEcCtD
Fluorescein—Anaphylactic shock—Etoposide—sarcoma	0.000287	0.00292	CcSEcCtD
Fluorescein—Asthenia—Thiotepa—sarcoma	0.000287	0.00292	CcSEcCtD
Fluorescein—Asthenia—Dactinomycin—sarcoma	0.000285	0.0029	CcSEcCtD
Fluorescein—Feeling abnormal—Mitoxantrone—sarcoma	0.000285	0.0029	CcSEcCtD
Fluorescein—Asthma—Epirubicin—sarcoma	0.000283	0.00288	CcSEcCtD
Fluorescein—Pruritus—Thiotepa—sarcoma	0.000283	0.00288	CcSEcCtD
Fluorescein—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000282	0.00288	CcSEcCtD
Fluorescein—Tachycardia—Etoposide—sarcoma	0.00028	0.00285	CcSEcCtD
Fluorescein—Abdominal pain—Vincristine—sarcoma	0.00028	0.00285	CcSEcCtD
Fluorescein—Skin disorder—Etoposide—sarcoma	0.000279	0.00284	CcSEcCtD
Fluorescein—Hyperhidrosis—Etoposide—sarcoma	0.000278	0.00283	CcSEcCtD
Fluorescein—Angina pectoris—Epirubicin—sarcoma	0.000276	0.00281	CcSEcCtD
Fluorescein—Urticaria—Mitoxantrone—sarcoma	0.000274	0.00279	CcSEcCtD
Fluorescein—Abdominal pain—Mitoxantrone—sarcoma	0.000273	0.00278	CcSEcCtD
Fluorescein—Hypotension—Etoposide—sarcoma	0.000268	0.00273	CcSEcCtD
Fluorescein—Dizziness—Thiotepa—sarcoma	0.000265	0.00269	CcSEcCtD
Fluorescein—Asthma—Doxorubicin—sarcoma	0.000262	0.00267	CcSEcCtD
Fluorescein—Hypersensitivity—Vincristine—sarcoma	0.000261	0.00266	CcSEcCtD
Fluorescein—Paraesthesia—Etoposide—sarcoma	0.000258	0.00263	CcSEcCtD
Fluorescein—Dyspnoea—Etoposide—sarcoma	0.000256	0.00261	CcSEcCtD
Fluorescein—Angina pectoris—Doxorubicin—sarcoma	0.000255	0.0026	CcSEcCtD
Fluorescein—Hypersensitivity—Mitoxantrone—sarcoma	0.000254	0.00259	CcSEcCtD
Fluorescein—Asthenia—Vincristine—sarcoma	0.000254	0.00259	CcSEcCtD
Fluorescein—Vomiting—Thiotepa—sarcoma	0.000254	0.00259	CcSEcCtD
Fluorescein—Vomiting—Dactinomycin—sarcoma	0.000252	0.00257	CcSEcCtD
Fluorescein—Rash—Thiotepa—sarcoma	0.000252	0.00257	CcSEcCtD
Fluorescein—Dermatitis—Thiotepa—sarcoma	0.000252	0.00257	CcSEcCtD
Fluorescein—Headache—Thiotepa—sarcoma	0.000251	0.00255	CcSEcCtD
Fluorescein—Rash—Dactinomycin—sarcoma	0.00025	0.00255	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Etoposide—sarcoma	0.000248	0.00253	CcSEcCtD
Fluorescein—Asthenia—Mitoxantrone—sarcoma	0.000248	0.00252	CcSEcCtD
Fluorescein—Pain—Etoposide—sarcoma	0.000246	0.0025	CcSEcCtD
Fluorescein—Nausea—Thiotepa—sarcoma	0.000238	0.00242	CcSEcCtD
Fluorescein—Feeling abnormal—Etoposide—sarcoma	0.000237	0.00241	CcSEcCtD
Fluorescein—Nausea—Dactinomycin—sarcoma	0.000236	0.0024	CcSEcCtD
Fluorescein—Gastrointestinal pain—Etoposide—sarcoma	0.000235	0.00239	CcSEcCtD
Fluorescein—Dizziness—Vincristine—sarcoma	0.000235	0.00239	CcSEcCtD
Fluorescein—Bradycardia—Epirubicin—sarcoma	0.000231	0.00235	CcSEcCtD
Fluorescein—Urticaria—Etoposide—sarcoma	0.000228	0.00232	CcSEcCtD
Fluorescein—Abdominal pain—Etoposide—sarcoma	0.000227	0.00231	CcSEcCtD
Fluorescein—Hypoaesthesia—Epirubicin—sarcoma	0.000226	0.0023	CcSEcCtD
Fluorescein—Vomiting—Vincristine—sarcoma	0.000226	0.0023	CcSEcCtD
Fluorescein—Rash—Vincristine—sarcoma	0.000224	0.00228	CcSEcCtD
Fluorescein—Dermatitis—Vincristine—sarcoma	0.000223	0.00227	CcSEcCtD
Fluorescein—Headache—Vincristine—sarcoma	0.000222	0.00226	CcSEcCtD
Fluorescein—Vomiting—Mitoxantrone—sarcoma	0.00022	0.00224	CcSEcCtD
Fluorescein—Rash—Mitoxantrone—sarcoma	0.000218	0.00222	CcSEcCtD
Fluorescein—Dermatitis—Mitoxantrone—sarcoma	0.000218	0.00222	CcSEcCtD
Fluorescein—Headache—Mitoxantrone—sarcoma	0.000216	0.0022	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—sarcoma	0.000214	0.00217	CcSEcCtD
Fluorescein—Hypersensitivity—Etoposide—sarcoma	0.000212	0.00215	CcSEcCtD
Fluorescein—Nausea—Vincristine—sarcoma	0.000211	0.00214	CcSEcCtD
Fluorescein—Cardiac disorder—Epirubicin—sarcoma	0.00021	0.00214	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—sarcoma	0.000209	0.00212	CcSEcCtD
Fluorescein—Asthenia—Etoposide—sarcoma	0.000206	0.0021	CcSEcCtD
Fluorescein—Angiopathy—Epirubicin—sarcoma	0.000206	0.00209	CcSEcCtD
Fluorescein—Nausea—Mitoxantrone—sarcoma	0.000205	0.00209	CcSEcCtD
Fluorescein—Immune system disorder—Epirubicin—sarcoma	0.000205	0.00208	CcSEcCtD
Fluorescein—Mediastinal disorder—Epirubicin—sarcoma	0.000204	0.00208	CcSEcCtD
Fluorescein—Chills—Epirubicin—sarcoma	0.000203	0.00207	CcSEcCtD
Fluorescein—Pruritus—Etoposide—sarcoma	0.000203	0.00207	CcSEcCtD
Fluorescein—Erythema—Epirubicin—sarcoma	0.000197	0.00201	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—sarcoma	0.000195	0.00198	CcSEcCtD
Fluorescein—Dysgeusia—Epirubicin—sarcoma	0.000193	0.00197	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—sarcoma	0.00019	0.00194	CcSEcCtD
Fluorescein—Dizziness—Etoposide—sarcoma	0.00019	0.00193	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—sarcoma	0.000189	0.00193	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—sarcoma	0.000189	0.00192	CcSEcCtD
Fluorescein—Chills—Doxorubicin—sarcoma	0.000188	0.00192	CcSEcCtD
Fluorescein—Ill-defined disorder—Epirubicin—sarcoma	0.000183	0.00186	CcSEcCtD
Fluorescein—Vomiting—Etoposide—sarcoma	0.000183	0.00186	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—sarcoma	0.000183	0.00186	CcSEcCtD
Fluorescein—Rash—Etoposide—sarcoma	0.000181	0.00184	CcSEcCtD
Fluorescein—Dermatitis—Etoposide—sarcoma	0.000181	0.00184	CcSEcCtD
Fluorescein—Headache—Etoposide—sarcoma	0.00018	0.00183	CcSEcCtD
Fluorescein—Dysgeusia—Doxorubicin—sarcoma	0.000179	0.00182	CcSEcCtD
Fluorescein—Malaise—Epirubicin—sarcoma	0.000178	0.00181	CcSEcCtD
Fluorescein—Syncope—Epirubicin—sarcoma	0.000177	0.0018	CcSEcCtD
Fluorescein—Loss of consciousness—Epirubicin—sarcoma	0.000173	0.00177	CcSEcCtD
Fluorescein—Cough—Epirubicin—sarcoma	0.000172	0.00175	CcSEcCtD
Fluorescein—Convulsion—Epirubicin—sarcoma	0.000171	0.00174	CcSEcCtD
Fluorescein—Nausea—Etoposide—sarcoma	0.000171	0.00174	CcSEcCtD
Fluorescein—Hypertension—Epirubicin—sarcoma	0.00017	0.00173	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—sarcoma	0.000169	0.00172	CcSEcCtD
Fluorescein—Chest pain—Epirubicin—sarcoma	0.000168	0.00171	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000167	0.0017	CcSEcCtD
Fluorescein—Discomfort—Epirubicin—sarcoma	0.000166	0.00169	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—sarcoma	0.000165	0.00168	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—sarcoma	0.000164	0.00167	CcSEcCtD
Fluorescein—Anaphylactic shock—Epirubicin—sarcoma	0.000161	0.00164	CcSEcCtD
Fluorescein—Oedema—Epirubicin—sarcoma	0.000161	0.00164	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—sarcoma	0.00016	0.00163	CcSEcCtD
Fluorescein—Cough—Doxorubicin—sarcoma	0.000159	0.00162	CcSEcCtD
Fluorescein—Shock—Epirubicin—sarcoma	0.000158	0.00161	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—sarcoma	0.000158	0.00161	CcSEcCtD
Fluorescein—Nervous system disorder—Epirubicin—sarcoma	0.000158	0.00161	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—sarcoma	0.000158	0.0016	CcSEcCtD
Fluorescein—Tachycardia—Epirubicin—sarcoma	0.000157	0.0016	CcSEcCtD
Fluorescein—Skin disorder—Epirubicin—sarcoma	0.000156	0.00159	CcSEcCtD
Fluorescein—Hyperhidrosis—Epirubicin—sarcoma	0.000156	0.00158	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—sarcoma	0.000155	0.00158	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000154	0.00157	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—sarcoma	0.000154	0.00156	CcSEcCtD
Fluorescein—Hypotension—Epirubicin—sarcoma	0.00015	0.00153	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—sarcoma	0.000149	0.00152	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—sarcoma	0.000149	0.00152	CcSEcCtD
Fluorescein—Shock—Doxorubicin—sarcoma	0.000147	0.00149	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—sarcoma	0.000146	0.00149	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—sarcoma	0.000145	0.00148	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—sarcoma	0.000145	0.00147	CcSEcCtD
Fluorescein—Paraesthesia—Epirubicin—sarcoma	0.000145	0.00147	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—sarcoma	0.000144	0.00147	CcSEcCtD
Fluorescein—Dyspnoea—Epirubicin—sarcoma	0.000144	0.00146	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—sarcoma	0.000139	0.00142	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Epirubicin—sarcoma	0.000139	0.00142	CcSEcCtD
Fluorescein—Pain—Epirubicin—sarcoma	0.000138	0.0014	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—sarcoma	0.000134	0.00136	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—sarcoma	0.000133	0.00135	CcSEcCtD
Fluorescein—Feeling abnormal—Epirubicin—sarcoma	0.000133	0.00135	CcSEcCtD
Fluorescein—Gastrointestinal pain—Epirubicin—sarcoma	0.000132	0.00134	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000129	0.00131	CcSEcCtD
Fluorescein—Urticaria—Epirubicin—sarcoma	0.000128	0.0013	CcSEcCtD
Fluorescein—Pain—Doxorubicin—sarcoma	0.000127	0.0013	CcSEcCtD
Fluorescein—Abdominal pain—Epirubicin—sarcoma	0.000127	0.0013	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—sarcoma	0.000123	0.00125	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—sarcoma	0.000122	0.00124	CcSEcCtD
Fluorescein—Hypersensitivity—Epirubicin—sarcoma	0.000119	0.00121	CcSEcCtD
Fluorescein—Urticaria—Doxorubicin—sarcoma	0.000118	0.00121	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—sarcoma	0.000118	0.0012	CcSEcCtD
Fluorescein—Asthenia—Epirubicin—sarcoma	0.000116	0.00118	CcSEcCtD
Fluorescein—Pruritus—Epirubicin—sarcoma	0.000114	0.00116	CcSEcCtD
Fluorescein—Hypersensitivity—Doxorubicin—sarcoma	0.00011	0.00112	CcSEcCtD
Fluorescein—Asthenia—Doxorubicin—sarcoma	0.000107	0.00109	CcSEcCtD
Fluorescein—Dizziness—Epirubicin—sarcoma	0.000107	0.00108	CcSEcCtD
Fluorescein—Pruritus—Doxorubicin—sarcoma	0.000105	0.00107	CcSEcCtD
Fluorescein—Vomiting—Epirubicin—sarcoma	0.000102	0.00104	CcSEcCtD
Fluorescein—Rash—Epirubicin—sarcoma	0.000102	0.00103	CcSEcCtD
Fluorescein—Dermatitis—Epirubicin—sarcoma	0.000101	0.00103	CcSEcCtD
Fluorescein—Headache—Epirubicin—sarcoma	0.000101	0.00103	CcSEcCtD
Fluorescein—Dizziness—Doxorubicin—sarcoma	9.85e-05	0.001	CcSEcCtD
Fluorescein—Nausea—Epirubicin—sarcoma	9.57e-05	0.000974	CcSEcCtD
Fluorescein—Vomiting—Doxorubicin—sarcoma	9.47e-05	0.000965	CcSEcCtD
Fluorescein—Rash—Doxorubicin—sarcoma	9.4e-05	0.000957	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—sarcoma	9.39e-05	0.000956	CcSEcCtD
Fluorescein—Headache—Doxorubicin—sarcoma	9.34e-05	0.00095	CcSEcCtD
Fluorescein—Nausea—Doxorubicin—sarcoma	8.85e-05	0.000901	CcSEcCtD
